1. Home
  2. USAC vs MIRM Comparison

USAC vs MIRM Comparison

Compare USAC & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USAC
  • MIRM
  • Stock Information
  • Founded
  • USAC 1998
  • MIRM 2018
  • Country
  • USAC United States
  • MIRM United States
  • Employees
  • USAC N/A
  • MIRM N/A
  • Industry
  • USAC Natural Gas Distribution
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • USAC Utilities
  • MIRM Health Care
  • Exchange
  • USAC Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • USAC 3.0B
  • MIRM 3.3B
  • IPO Year
  • USAC N/A
  • MIRM 2019
  • Fundamental
  • Price
  • USAC $24.22
  • MIRM $74.31
  • Analyst Decision
  • USAC Hold
  • MIRM Strong Buy
  • Analyst Count
  • USAC 4
  • MIRM 10
  • Target Price
  • USAC $25.50
  • MIRM $74.20
  • AVG Volume (30 Days)
  • USAC 157.9K
  • MIRM 746.3K
  • Earning Date
  • USAC 11-04-2025
  • MIRM 11-11-2025
  • Dividend Yield
  • USAC 8.68%
  • MIRM N/A
  • EPS Growth
  • USAC 24.37
  • MIRM N/A
  • EPS
  • USAC 0.66
  • MIRM N/A
  • Revenue
  • USAC $981,219,000.00
  • MIRM $429,161,000.00
  • Revenue This Year
  • USAC $7.21
  • MIRM $52.71
  • Revenue Next Year
  • USAC $4.61
  • MIRM $19.71
  • P/E Ratio
  • USAC $36.46
  • MIRM N/A
  • Revenue Growth
  • USAC 8.22
  • MIRM 62.33
  • 52 Week Low
  • USAC $21.24
  • MIRM $36.86
  • 52 Week High
  • USAC $30.10
  • MIRM $78.10
  • Technical
  • Relative Strength Index (RSI)
  • USAC 55.05
  • MIRM 63.07
  • Support Level
  • USAC $23.01
  • MIRM $73.70
  • Resistance Level
  • USAC $24.05
  • MIRM $77.96
  • Average True Range (ATR)
  • USAC 0.55
  • MIRM 2.48
  • MACD
  • USAC 0.01
  • MIRM -0.54
  • Stochastic Oscillator
  • USAC 82.03
  • MIRM 48.19

About USAC USA Compression Partners LP Common Units Representing Limited Partner Interests

USA Compression Partners LP provides compression services in the United States in terms of total compression fleet horsepower to customers relating to infrastructure applications, including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. It engineers, designs, operates, services, and repairs its compression units and maintains related support inventory and equipment. The company provides compression services in several shale plays throughout the U.S., including the Utica, Marcellus, Permian, Denver-Julesburg, Eagle Ford, Mississippi Lime, Granite Wash, Woodford, Barnett, and Haynesville.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: